A randomized, double-blind trial of amorolfine 0.25% cream and sertaconazole 2% cream in limited dermatophytosis-Reference-Cited by-同舟云学术

A randomized, double-blind trial of amorolfine 0.25% cream and sertaconazole 2% cream in limited dermatophytosis

Published:2019 Issue:3 Volume:85 Page:276
ISSN:0378-6323
Container-title:Indian Journal of Dermatology, Venereology and Leprology
language:en
Short-container-title:Indian J Dermatol Venereol Leprol

Author:

Sil Amrita,Das Anirban,Sarkar TusharKanti,Sen Arpita,Chakravorty Sriparna,Sengupta Manideepa,Das Anupam,Chandra Somodyuti,Pal Santasmita,Bandyopadhyay Debabrata,Das NilayKanti

Publisher

Scientific Scholar

Subject

Infectious Diseases,Dermatology

Reference11 articles.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Amorolfine Lotion 0.25% w/v Compared to Amorolfine Cream 0.25% w/w in Patients With Superficial Fungal Infections of the Skin: A Multi-center, Randomized, Open-Label, Active-Controlled, Non-inferiority Phase III Clinical Trial;Cureus;2024-05-12

2. Entangled: The New Era of Aggressive Dermatomycosis;Critical Thinking in Contemporary Dermatology: Cognitive Essays;2024

3. A systematic review of 454 randomized controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries;British Journal of Dermatology;2023-03-27

4. Assessing the efficacy and safety of Unani pharmacopoeial formulations in dermatophytosis (quba) – a randomized controlled trial;Drug Metabolism and Personalized Therapy;2022-08-24

5. The unprecedented epidemic-like scenario of dermatophytosis in India: III. Antifungal resistance and treatment options;Indian Journal of Dermatology, Venereology and Leprology;2021-06-30